Glaukos (NYSE:GKOS) said today that it acquired Dose Medical‘s intraocular pressure sensor system assets for $5.5 million in cash, plus $9.5 million contingent upon development, clinical and regulatory milestones.
The Dose Medical IOP sensor system includes a micro-invasive ocular implant that captures and stores a glaucoma patient’s short-interval IOP measurements. The system transmits data to the patient’s physician in the hopes of enhancing treatment.
Get the full story at our sister site, Drug Delivery Business News.
The post Glaukos drops $6m on Dose Medical’s IOP sensor system appeared first on MassDevice.
from MassDevice http://ift.tt/2paG6XO
Cap comentari:
Publica un comentari a l'entrada